Samuel Kintz
Fondateur chez ENLIVEN THERAPEUTICS, INC.
Fortune : 21 M $ au 30/04/2024
Profil
Samuel S.
Kintz is the founder of Enliven Therapeutics, Inc. (founded in 2019) and currently holds the titles of President, Chief Executive Officer & Director.
Mr. Kintz's education history includes an undergraduate degree from Stanford University and an MBA from Stanford Graduate School of Business.
Mr. Kintz is also the founder of Enliven Therapeutics, Inc...
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/04/2024 | 1 264 587 ( 2,70% ) | 21 M $ | 30/04/2024 |
Postes actifs de Samuel Kintz
| Sociétés | Poste | Début |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Fondateur | 01/06/2019 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Fondateur | - |
Formation de Samuel Kintz
| Stanford University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |